Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma

Br J Dermatol. 2018 Oct;179(4):993-994. doi: 10.1111/bjd.16780. Epub 2018 Jul 23.

Authors

V Haug¹, V Behle¹, S Benoit¹, H Kneitz¹, B Schilling¹, M Goebeler¹, A Gesierich¹

Affiliation

¹ Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080, Würzburg, Germany.

PMID: 29758087
DOI: 10.1111/bjd.16780

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Carcinoma, Merkel Cell / drug therapy*
Humans
Male
Middle Aged
Mouth Mucosa / drug effects
Mouth Mucosa / immunology
Mouth Mucosa / pathology
Pemphigoid, Benign Mucous Membrane / chemically induced*
Pemphigoid, Benign Mucous Membrane / immunology
Pemphigoid, Benign Mucous Membrane / pathology
Programmed Cell Death 1 Receptor / antagonists & inhibitors
Programmed Cell Death 1 Receptor / immunology
Skin Neoplasms / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
PDCD1 protein, human
Programmed Cell Death 1 Receptor
pembrolizumab